Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin.
Nakamura N, Yamauchi T, Hiramoto M, Yuri M, Naito M, Takeuchi M, Yamanaka K, Kita A, Nakahara T, Kinoyama I, Matsuhisa A, Kaneko N, Koutoku H, Sasamata M, Yokota H, Kawabata S, Furuichi K. Nakamura N, et al. Mol Cell Proteomics. 2012 Jul;11(7):M111.013243. doi: 10.1074/mcp.M111.013243. Epub 2012 Mar 22. Mol Cell Proteomics. 2012. PMID: 22442257 Free PMC article.
Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.
Yamauchi T, Nakamura N, Hiramoto M, Yuri M, Yokota H, Naitou M, Takeuchi M, Yamanaka K, Kita A, Nakahara T, Kinoyama I, Matsuhisa A, Kaneko N, Koutoku H, Sasamata M, Kobori M, Katou M, Tawara S, Kawabata S, Furuichi K. Yamauchi T, et al. Among authors: nakamura n. Biochem Biophys Res Commun. 2012 Sep 7;425(4):711-6. doi: 10.1016/j.bbrc.2012.07.103. Epub 2012 Jul 27. Biochem Biophys Res Commun. 2012. PMID: 22842455
Combination of MS protein identification and bioassay of chromatographic fractions to identify biologically active substances from complex protein sources.
Kuromitsu S, Yokota H, Hiramoto M, Yuri M, Naitou M, Nakamura N, Kawabata S, Kobori M, Katoh M, Furuchi K, Mita H, Yamada T. Kuromitsu S, et al. Among authors: nakamura n. Mol Cell Proteomics. 2009 Jun;8(6):1318-23. doi: 10.1074/mcp.M800491-MCP200. Epub 2009 Feb 3. Mol Cell Proteomics. 2009. PMID: 19193608 Free PMC article.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
Iihara H, Abe M, Wada M, Iino K, Akechi T, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K. Iihara H, et al. Among authors: nakamura n. Int J Clin Oncol. 2024 May 16. doi: 10.1007/s10147-024-02535-x. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38753042
Comparison between single-muscle evaluation and cross-sectional area muscle evaluation for predicting the prognosis in patients with oral squamous cell carcinoma: a retrospective cohort study.
Takayama H, Yoshimura T, Suzuki H, Hirano Y, Tezuka M, Ishida T, Ishihata K, Amitani M, Amitani H, Nakamura Y, Imamura Y, Inui A, Nakamura N. Takayama H, et al. Among authors: nakamura n. Front Oncol. 2024 May 1;14:1336284. doi: 10.3389/fonc.2024.1336284. eCollection 2024. Front Oncol. 2024. PMID: 38751815 Free PMC article.
Artificial intelligence and classification of mature lymphoid neoplasms.
Carreras J, Hamoudi R, Nakamura N. Carreras J, et al. Among authors: nakamura n. Explor Target Antitumor Ther. 2024;5(2):332-348. doi: 10.37349/etat.2024.00221. Epub 2024 Apr 23. Explor Target Antitumor Ther. 2024. PMID: 38745770 Free PMC article. Review.
3,746 results